ZBH

SEC source: 0001062993-24-004684 · form4.xml · nonDerivative · entry 1

Yi Sang · CIK 0001635943 · Group President, Asia Pacific

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,762

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

F2 · balance_after: Includes 188 shares acquired under the Company's Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 1, 2024.

SEC source: 0001062993-24-004448 · form4.xml · derivative · entry 4

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,156 shares

Expires 2024-03-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Fully vested.

SEC source: 0001062993-24-004448 · form4.xml · nonDerivative · entry 3

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,145

F3 · price: Reflects the weighted average price of 610 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on February 22, 2024 with sale prices ranging from $129.06 to $129.11 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price.

SEC source: 0001062993-24-004448 · form4.xml · nonDerivative · entry 2

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,755

F2 · price: Reflects the weighted average price of 25,546 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on February 22, 2024 with sale prices ranging from $128.03 to $128.99 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price.

SEC source: 0001062993-24-004448 · form4.xml · nonDerivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,301

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 474 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 1, 2024.

SEC source: 0001062993-24-004140 · form4.xml · derivative · entry 1

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,104

Underlying: Common Stock · 2,104 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

SEC source: 0001062993-24-004139 · form4.xml · derivative · entry 1

Bezjak Mark · CIK 0002004536 · President, Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,556

Underlying: Common Stock · 7,556 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

SEC source: 0001062993-24-004138 · form4.xml · derivative · entry 1

VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,352

Underlying: Common Stock · 7,352 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

SEC source: 0001062993-24-004137 · form4.xml · derivative · entry 1

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,718

Underlying: Common Stock · 5,718 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

SEC source: 0001062993-24-004136 · form4.xml · derivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,739

Underlying: Common Stock · 6,739 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

SEC source: 0001062993-24-004135 · form4.xml · derivative · entry 1

Yi Sang · CIK 0001635943 · Group President, Asia Pacific

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,147

Underlying: Common Stock · 7,147 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

SEC source: 0001062993-24-004134 · form4.xml · derivative · entry 1

Tornos Ivan · CIK 0001757216 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,987

Underlying: Common Stock · 47,987 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

SEC source: 0001062993-24-004133 · form4.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,336

Underlying: Common Stock · 16,336 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

SEC source: 0001062993-24-004132 · form4.xml · derivative · entry 1

Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,697

Underlying: Common Stock · 4,697 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

SEC source: 0001062993-24-000259 · form4.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,883.107

Underlying: Common Stock · 128.263 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 6.005 phantom stock units accrued on October 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-24-000258 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,453.707

Underlying: Common Stock · 492.53 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 40.004 phantom stock units accrued on October 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-24-000257 · form4.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,811.555

Underlying: Common Stock · 256.526 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 41.951 phantom stock units accrued on October 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-24-000256 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,373.452

Underlying: Common Stock · 266.787 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 29.421 phantom stock units accrued on October 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. This amount also reflects the deduction of 33.198 units to correct an error in the reporting person's Form 4 filed on October 3, 2023, in which the number of phantom stock units received by the reporting person on September 30, 2023, and the total number of phantom stock units held by the reporting person following that date, were over-reported by 33.198 units.

SEC source: 0001062993-24-000255 · form4.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,986.295

Underlying: Common Stock · 225.743 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 26.433 phantom stock units accrued on October 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-24-000254 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,987.886

Underlying: Common Stock · 112.871 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 10.909 phantom stock units accrued on October 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-24-000253 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,380.889

Underlying: Common Stock · 225.743 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: The units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 15.863 phantom stock units accrued on October 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-24-000252 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,835.836

Underlying: Common Stock · 225.743 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 71.990 phantom stock units accrued on October 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. This amount also reflects the deduction of 44.263 units to correct an error in the reporting person's Form 4 filed on October 3, 2023, in which the number of phantom stock units received by the reporting person on September 30, 2023, and the total number of phantom stock units held by the reporting person following that date, were over-reported by 44.263 units.

SEC source: 0001062993-24-000251 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,190.104

Underlying: Common Stock · 277.048 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 61.083 phantom stock units accrued on October 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-020641 · form4.xml · nonDerivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,060

SEC source: 0001062993-23-018799 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,921.173

Underlying: Common Stock · 531.161 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 29.639 phantom stock units accrued on July 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-018798 · form4.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,513.078

Underlying: Common Stock · 276.647 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 31.177 phantom stock units accrued on July 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-018797 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,110.442

Underlying: Common Stock · 320.91 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 21.696 phantom stock units accrued on July 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-018796 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,851.973

Underlying: Common Stock · 298.778 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 45.535 phantom stock units accrued on July 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-018795 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,582.366

Underlying: Common Stock · 287.712 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 53.751 phantom stock units accrued on July 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-018794 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,139.283

Underlying: Common Stock · 243.449 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: The units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 11.604 phantom stock units accrued on July 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-018793 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,864.106

Underlying: Common Stock · 121.725 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 8.041 phantom stock units accrued on July 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-018792 · form4.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,748.839

Underlying: Common Stock · 138.324 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 4.331 phantom stock units accrued on July 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-018791 · form4.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,734.119

Underlying: Common Stock · 243.449 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 19.552 phantom stock units accrued on July 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-23-017670 · form4.xml · derivative · entry 1

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,281

Underlying: Common Stock · 1,281 shares

Expires 2025-09-01

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

SEC source: 0001062993-23-017669 · form4.xml · derivative · entry 1

Tornos Ivan · CIK 0001757216 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,491

Underlying: Common Stock · 14,491 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests in increments of one-third on each of March 6, 2024, March 6, 2025 and March 6, 2026.

F2 · derivative.expiration_date: Vests in increments of one-third on each of March 6, 2024, March 6, 2025 and March 6, 2026.

SEC source: 0001062993-23-017404 · form4.xml · nonDerivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

SEC source: 0001062993-23-017272 · form4.xml · nonDerivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

SEC source: 0001062993-23-018607 · form4.xml · nonDerivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,540

SEC source: 0001062993-23-017223 · form4.xml · nonDerivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,385

SEC source: 0001062993-23-017221 · form4.xml · nonDerivative · entry 2

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,271

F2 · balance_after: Includes 4,250 shares of common stock purchased by the reporting person on February 6, 2019, which was reported on a Form 4 filed by the reporting person on February 6, 2019.

SEC source: 0001062993-23-017116 · form4.xml · nonDerivative · entry 2

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,400

SEC source: 0001062993-23-017116 · form4.xml · nonDerivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,900

SEC source: 0001062993-23-014443 · form4.xml · derivative · entry 2

VAN ZUILEN WILFRED · CIK 0001864818 · Pres, Europe, M. East & Africa

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,264

Underlying: Common Stock · 2,633 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: 2,633 of the RSUs vested on July 1, 2023 and the remaining 5,264 RSUs are scheduled to vest 50% on each of July 1, 2024 and 2025.

F3 · derivative.expiration_date: 2,633 of the RSUs vested on July 1, 2023 and the remaining 5,264 RSUs are scheduled to vest 50% on each of July 1, 2024 and 2025.

SEC source: 0001062993-23-014443 · form4.xml · nonDerivative · entry 1

VAN ZUILEN WILFRED · CIK 0001864818 · Pres, Europe, M. East & Africa

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,073

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 200 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan on June 30, 2022 and December 30, 2022.

SEC source: 0001062993-23-014447 · form4.xml · derivative · entry 3

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,768 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F3 · derivative.exercise_date: The remaining 3,768 RSUs in this grant vested on July 1, 2023.

F3 · derivative.expiration_date: The remaining 3,768 RSUs in this grant vested on July 1, 2023.

SEC source: 0001062993-23-014447 · form4.xml · nonDerivative · entry 2

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,983

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-23-014447 · form4.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001062993-23-014483 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,360.373

Underlying: Common Stock · 255.955 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

SEC source: 0001062993-23-014481 · form4.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,205.254

Underlying: Common Stock · 213.296 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

SEC source: 0001062993-23-014479 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,733.709

Underlying: Common Stock · 213.296 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.